LIPAD
LIVE

Serial Number

86945392

Owner

Taiwan Liposome Co., Ltd.

Attorney

Joe McKinney Muncy

Filing Date

Mar 18, 2016

Add to watchlist:

No watchlists yet
View on USPTO

LIPAD Trademark

Serial Number: 86945392 • Registration: 5760160

LIPAD is a trademark filed by Taiwan Liposome Co., Ltd. on March 18, 2016. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Taiwan Liposome Co., Ltd. (24 trademarks)

11F-1, No.3, Yuan Cyu St., Nankang Dist.
Taipei , TW

Entity Type: 03

Trademark Details

Filing Date

March 18, 2016

Registration Date

May 28, 2019

Published for Opposition

March 12, 2019

Goods & Services

[ Allergy medications; antibacterial pharmaceuticals; antibiotic preparations; antibiotics; antifungal preparations; anti-cancer preparations; anti-diabetic preparations; anti-inflammatories; aspirin; lipid-based preparations for medical or clinical use; cardiovascular treatment preparations; cells for medical or clinical use; chemotherapeutics; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; medicated skin care preparations; ophthalmic preparations; pain relief medication; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; pharmaceutical products for ophthalmological use; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; radioactive pharmaceutical preparations for therapeutic use ]

Biochemical research and development; biomedical research services; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; chemical, biochemical, biological and bacteriological research and analysis; development of pharmaceutical preparations and medicines; medical and scientific research, namely, conducting clinical trials for others; medical research services relating to diagnostics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; product development in the field of biopharmaceutical; pharmaceutical research services; pharmaceutical drug development services; research and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines; technical research in the field of drug delivery systems

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jan 31, 2025 NA85
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jan 31, 2025 C15P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 31, 2025 APRE
TEAS SECTION 8 & 15 RECEIVED
Sep 16, 2024 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
May 28, 2024 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 23, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Dec 23, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 23, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 23, 2022 REAP
REGISTERED-PRINCIPAL REGISTER
May 28, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 12, 2019 NPUB
PUBLISHED FOR OPPOSITION
Mar 12, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 20, 2019 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 6, 2019 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 29, 2019 CNSA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jan 29, 2019 ZZZX
CASE RETURNED TO EXAMINATION
Jan 28, 2019 OTHE
ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
Jan 22, 2019 ATRQ
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Jan 22, 2019 PCBG
NOTICE OF ALLOWANCE CANCELLED
Jan 14, 2019 IUCN
TEAS RESPONSE TO PETITION INQUIRY LETTER
Jan 14, 2019 ERTI
PETITION INQUIRY LETTER ISSUED
Jan 14, 2019 PILM
ASSIGNED TO PETITION STAFF
Jan 14, 2019 APET
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 6, 2018 EXRA
SOU EXTENSION 3 GRANTED
Nov 2, 2018 EX3G
SOU EXTENSION 3 FILED
Nov 2, 2018 EXT3
SOU TEAS EXTENSION RECEIVED
Nov 2, 2018 EEXT
TEAS PETITION TO DIRECTOR RECEIVED
Nov 2, 2018 TPDR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 18, 2018 EXRA
SOU EXTENSION 2 GRANTED
May 16, 2018 EX2G
SOU EXTENSION 2 FILED
May 16, 2018 EXT2
SOU TEAS EXTENSION RECEIVED
May 16, 2018 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 18, 2017 EXRA
SOU EXTENSION 1 GRANTED
Nov 16, 2017 EX1G
SOU EXTENSION 1 FILED
Nov 16, 2017 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 16, 2017 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 16, 2017 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 21, 2017 NPUB
PUBLISHED FOR OPPOSITION
Mar 21, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 1, 2017 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 13, 2017 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 27, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 25, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 25, 2017 CRFA
ASSIGNED TO LIE
Jan 20, 2017 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 27, 2016 TROA
NOTIFICATION OF NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED
Sep 12, 2016 GAUN
NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED
Sep 12, 2016 GAUD
REPORT UNRESPONSIVE AMENDMENT - COMPLETED
Sep 12, 2016 NAUD
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Sep 8, 2016 AMPX
TEAS VOLUNTARY AMENDMENT RECEIVED
Sep 8, 2016 PARI
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 28, 2016 GNRN
NON-FINAL ACTION E-MAILED
Jun 28, 2016 GNRT
NON-FINAL ACTION WRITTEN
Jun 28, 2016 CNRT
ASSIGNED TO EXAMINER
Jun 28, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 23, 2016 NWOS
NEW APPLICATION ENTERED
Mar 22, 2016 NWAP